维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Flynn RE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Systemic complement depletion reduces inflammation anddemyelination in adoptive transfer experimental allergic neuritis显示文摘	Vriesendorp FJ Flynn RE Malone MR	1998	Acta Neuropathol(Berl)1998，95，3：	1
2	Soluble complement receptor1(sCR1)is not as effective as cobra venom factor in the treatment of experimental allergic neuritis显示文摘	Vriesendorp FJ Flynn RE Pappolla MA		0，，3：	1
3	Antihistamine and /or decongestants for otitis media with effusion (OME) in children 显示文摘	Griffin GH Flynn C Bailey RE	2006	Coehrane database of systematic reviews (Online)2006，，：	1
4	Status consumption in consumer behavior: scale development and validation显示文摘	Eastman JK Goldsmith RE Flynn LR		0，，03：	1
5	Contact lens wear at altitude: Subcontact lens bubble formation 显示文摘	Flynn WJ Miller RE Tredici TJ	1987	Aviat Space Environ Med1987，58，11：	1
6	The metabolic basis ofargine nutrition and pharmacotherapy显示文摘	Meininger CJ Haynes TE	2002	Biomed Pharm acother2002，56，9：	1
7	Long-term visual outcomes in patients with successful macular hole surgery 显示文摘	Leonard RE 2nd Smiddy WE Flynn HW Jr	1997	Ophthalmology1997，104，：	1
8	Soluble copmlement receptor 1 ( sCR1 ) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis 显示文摘	Flynn RE Papolla MA	1997	Int J Neurosci1997，92，34：	1
9	Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer: results from NSABP C-07显示文摘	Kuebler JP Wieand HS O’Connell MJ Smith RE Colangelo LH Yothers G Petrelli NJ Findlay MP Seay TE Atkins JN Zapas JL Goodwin JW Fehrenbacher L Ramanathan RK Conley BA Flynn PJ Soori G Colman LK Levine EA Lanier KS Wolmark N	2007	J Clin Oncol2007，25，16：	1
10	Useful visual outcomes after treatment of bacillus cereus endophthalmitis显示文摘	Foster RE Martinez JA Murray TG Rubsamen PE Flynn Jr HW Forster RK	1996	Ophthalmology1996，103，：	1
11	Botulinum toxin type B (MYOBLOC)ver- sus botulinum toxin type A (BOTOX)frontalis study:rate of onset and radius of diffusion 显示文摘	Flynn TC Clark RE 2nd	2003	Dermatol Surg2003，29，5：	1
12	Soluble comple- ment receptor is not as effective as cobra verom factor in the treatment of experimental allergic neuritis显示文摘	Vriesemdor PFJ Flynn RE Papolla MA	1997	Int J Neuro Sci1997，92，3：	1
13	Contact lens wear at altitude: Subeontact lens bubble formation 显示文摘	Flynn W J Miller RE Tredici T J	1987	Aviat Space Environ Med1987，58，11：	1
14	Observational study of accuracy in compounding iv admixtures at five hospital 显示文摘	Flynn EA Pearson RE Barker KN	1997	Am J Health Syst Pharm1997，54，8：	1
15	Observational study of accuracy in compounding iv admixtures at five hospital显示文摘	Flynn EA Pearson RE Barker KN	1997	Am J Health Syst Pharm1997，54，8：	1
16	Long-termvisual outcomes in patients with successful macular hole surgery显示文摘	Leonard RE 2nd Smiddy WE Flynn HW Jr	1997	Ophthalmology1997，104，10：	1
17	Botulinum toxin type B (Myobloc) ver- sus botulinum toxin type A (BOTOX) frontalis study: rate o{ onset and radius of diffusion 显示文摘	Flynn TC Clark RE	2003	Dermatol Surg2003，29，5：	1
18	Soluble eoprrdement receptor(sCR1 ) is not as effective as cobra venom factor in the treatment of experimental allergic nruritis 显示文摘	Vriesendorp FJ Flynn RE Papolla MA	1997	Int J Neurosci1997，92，34：	1
19	Soluble copmlement receptor(sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic muritis显示文摘	Vriesendorp FJ Flynn RE Papolla MA	1997	Int J Neurosci1997，92，34：	1
20	Antihistamines and/or decongestants for otitis media with effusion ( OME ) in children 显示文摘	Griffin GH Flynn C Bailey RE	2006	Cochrane Database Syst Rev2006，18，00：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示